Hemispherian
As Chief Scientific Officer, Adam is responsible for all scientific endeavors at Hemispherian. He has a PhD from the University of North Carolina at Chapel Hill, USA. After securing several major grants, he established his own lab at Oslo University Hospital. His team successfully identified Hemispherian’s lead pharmaceuticals and their mechanism of action.
Adam left academia to pursue the newly discovered drug candidates with Hemispherian.
Hemispherian
Hemispherian is a biotechnology company developing new treatments for the most aggressive types of cancer. Its mission is to development a new drug to treat Glioblastoma Multiforme.